Mizuho Securities USA LLC Increases Stake in IQVIA Holdings Inc. (NYSE:IQV)

Mizuho Securities USA LLC increased its position in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 1,397.9% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 210,428 shares of the medical research company's stock after acquiring an additional 196,380 shares during the quarter. Mizuho Securities USA LLC owned about 0.12% of IQVIA worth $49,865,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. PGGM Investments increased its holdings in shares of IQVIA by 55.8% in the second quarter. PGGM Investments now owns 12,073 shares of the medical research company's stock worth $2,553,000 after purchasing an additional 4,326 shares during the period. Quadrature Capital Ltd purchased a new stake in shares of IQVIA in the 1st quarter valued at about $3,365,000. Simplify Asset Management Inc. boosted its position in shares of IQVIA by 67.8% during the 3rd quarter. Simplify Asset Management Inc. now owns 9,637 shares of the medical research company's stock valued at $2,284,000 after acquiring an additional 3,894 shares during the last quarter. Raymond James & Associates grew its holdings in shares of IQVIA by 0.7% during the second quarter. Raymond James & Associates now owns 800,374 shares of the medical research company's stock worth $169,231,000 after purchasing an additional 5,417 shares in the last quarter. Finally, UniSuper Management Pty Ltd increased its position in shares of IQVIA by 253.0% in the first quarter. UniSuper Management Pty Ltd now owns 6,029 shares of the medical research company's stock worth $1,525,000 after purchasing an additional 4,321 shares during the last quarter. Hedge funds and other institutional investors own 89.62% of the company's stock.

IQVIA Trading Down 5.1 %

IQV stock traded down $10.26 on Friday, reaching $192.68. The company's stock had a trading volume of 4,579,136 shares, compared to its average volume of 1,143,450. IQVIA Holdings Inc. has a 12-month low of $189.63 and a 12-month high of $261.73. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. The business has a fifty day simple moving average of $226.95 and a two-hundred day simple moving average of $228.29. The firm has a market cap of $34.97 billion, a PE ratio of 25.28, a PEG ratio of 2.17 and a beta of 1.51.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. TD Cowen decreased their price target on shares of IQVIA from $270.00 to $255.00 and set a "buy" rating on the stock in a report on Friday, November 1st. Royal Bank of Canada reaffirmed an "outperform" rating and set a $270.00 price target on shares of IQVIA in a research note on Friday, November 1st. Truist Financial reduced their price objective on IQVIA from $286.00 to $265.00 and set a "buy" rating on the stock in a research report on Monday, November 4th. Argus upgraded IQVIA to a "strong-buy" rating in a research report on Wednesday, July 31st. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on shares of IQVIA from $270.00 to $265.00 and set a "buy" rating on the stock in a research report on Friday, November 1st. Five equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $259.13.

Insiders Place Their Bets

In related news, insider Eric Sherbet sold 1,300 shares of the business's stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $246.33, for a total transaction of $320,229.00. Following the sale, the insider now owns 19,536 shares of the company's stock, valued at $4,812,302.88. The trade was a 6.24 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 1.60% of the company's stock.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.